ArticleJournal of translational medicine2025

IL33-ST2 axis is a predictive biomarker for anti-PD1 therapeutic efficacy in advanced gastric cancer.

Chie Kudo-Saito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.